title: Factor VIII products and inhibitor development: concepts for revision of European regulatory guidelines.
authors: B
authors: B
authors: Neugebauer
authors: C
authors: C
authors: Drai
authors: M
authors: M
authors: Haase
authors: A
authors: A
authors: Hilger
authors: B
authors: B
authors: Keller-Stanislawski
authors: P
authors: P
authors: Laitinen-Parkkonen
authors: D
authors: D
authors: Mentzer
authors: C
authors: C
authors: Rasmussen
authors: C
authors: C
authors: Ratignier
authors: R
authors: R
authors: Seitz
mesh_terms: D002985:Clinical Protocols / Q000592:standards; D002986:Clinical Trials as Topic / Q000592:standards; D005169:Factor VIII / Q000276:immunology* / Q000627:therapeutic use*; D006801:Humans; D007518:Isoantibodies / Q000097:blood; D017410:Practice Guidelines as Topic / Q000592:standards*
chemical_list: D007518:Isoantibodies; D005169:Factor VIII